We aimed to investigate the effect of switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) on the hepatic safety and metabolic profile.
The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile
Falasca, Katia;
2020-01-01
Abstract
We aimed to investigate the effect of switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) on the hepatic safety and metabolic profile.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
the-effect-of-switching-from-tenofovir-disoproxil-fumarate-.pdf
accesso aperto
Dimensione
373.14 kB
Formato
Adobe PDF
|
373.14 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
